This column is my opinion and expresses my views. Those views can change at a moments notice when the market changes. I am not right all the time and I do not expect to be. I disclose all my positions clearly listed on the page, and I do not trade my account on the stocks spoken of in this column unless fully disclosed. If that does not work for you stop reading and close the page. Do not bother me or harass me.
Otherwise, enjoy the column!
Subscribe to the Monster Stock Market Commentary to get the Daily Monster Market Commentary and join the 2,936 subscribers getting it for FREE!
The Nasdaq has recouped all of yesterday’s losses today.
With the Nasdaq bouncing off our February 2016 trend line.
(Interactive Brokers TWS)
The S&P 500 is setting up nicely after yesterday move lower as well.
Subscribe to the MCM Stock Market Commentary to get it Daily and join the 2,936 subscribers getting it for FREE!
The resilience of the overall market is overwhelming bullish with Technology and Biotech leading the way. The S&P 500 is ready and primed for its next leg higher on to our 2,550 target. This time with a Biotech group that is ready to participate.
Get A Free Reading The Market Premium Video Segment
Watch my interview from this morning on Cheddar.tv.
The chip companies that most stand to benefit from Apple’s new iPhone 8 release this fall.
Let Us Write Research For you.
Free Articles By Mike
Michael Kramer is the Founder and Portfolio Manager of Mott Capital Management LLC, a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendation made during the past twelve months. Past performance is not indicative of future performance.